Number of the records: 1  

Preclinical Evaluation of (177)Lu-Nimotuzumab: A Potential Tool for Radioimmunotherapy of Epidermal Growth Factor Receptor-Overexpressing Tumors

  1. 1.
    SYSNO0365501
    TitlePreclinical Evaluation of (177)Lu-Nimotuzumab: A Potential Tool for Radioimmunotherapy of Epidermal Growth Factor Receptor-Overexpressing Tumors
    Author(s) Beckford, Denis R. (UJF-V) [ORF] RID
    Eigner, Sebastian (UJF-V) [ORF] RID
    Beran, Miloš (UJF-V) [ORF]
    Eigner-Henke, Kateřina (UJF-V) [ORF] RID
    Lázníček, M. (CZ)
    Melichar, František (UJF-V) [ORF] RID
    Chinol, M. (IT)
    Source Title Cancer Biotherapy and Radiopharmaceuticals. Roč. 26, č. 3 (2011), s. 287-297
    Document TypeČlánek v odborném periodiku
    Grant OE08018 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z10480505 - UJF-V (2005-2011)
    Languageeng
    CountryUS
    Keywords EGFR * (177)Lu * monoclonal antibodies * Nimotuzumab
    Permanent Linkhttp://hdl.handle.net/11104/0200730
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.